Comparison of Minimum Flow and Low Flow Desflurane Anesthesia in Robotic Assisted Laparoscopic Abdominal Surgery
NCT ID: NCT06520943
Last Updated: 2024-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
70 participants
OBSERVATIONAL
2024-07-15
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low and Moderete Flow Anaesthesia on Haemodynamics
NCT06871371
Evaluation of Low Flow and Normal Flow Anesthesia Management in Robotic Assisted Laparoscopic Surgeries
NCT06430593
Low-Flow Desflurane Anesthesia and Its Effects on BIS and Postoperative Cognitive Functions
NCT07212543
The Effect of Flow-controlled Ventilation on Hemodynamic and Respiratory Parameters in Laparoscopic Surgeries
NCT06274372
The Effects of Automatic Gas-Controlled Low-Flow Anesthesia on Anesthetic Agent Consumption in Elective Surgeries
NCT06735937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
After intubation, a fresh gas flow of 3 L/min will be applied for the first 20 minutes and then reduced to 0.5 L/min.
blood gas analysis
1. Airway pressure (P plateau, Ppeak) values are taken from the anesthesia device data,
2. BIS (from routine BIS monitoring)
3. Temperature (routinely from pharyngeal temperature probe),
4. Oxygen saturation (routinely from the patient monitor)
5. End-tidal CO₂,
6. inspiratory O₂ concentration,
7. Inspiratory CO2 concentration,
8. inspiratory and expiratory desflurane concentrations,
9. tidal volume,
10. MAC is routinely obtained from anesthesia device data.
11. Blood Gas Analysis (COHgb, Ph, PO2, PCO2, SaO2, HCO3, Base deficit, glucose, lactate)
Group 2
After intubation, a fresh gas flow of 3 L/min will be applied for the first 20 minutes and then reduced to 1 L/min.
blood gas analysis
1. Airway pressure (P plateau, Ppeak) values are taken from the anesthesia device data,
2. BIS (from routine BIS monitoring)
3. Temperature (routinely from pharyngeal temperature probe),
4. Oxygen saturation (routinely from the patient monitor)
5. End-tidal CO₂,
6. inspiratory O₂ concentration,
7. Inspiratory CO2 concentration,
8. inspiratory and expiratory desflurane concentrations,
9. tidal volume,
10. MAC is routinely obtained from anesthesia device data.
11. Blood Gas Analysis (COHgb, Ph, PO2, PCO2, SaO2, HCO3, Base deficit, glucose, lactate)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood gas analysis
1. Airway pressure (P plateau, Ppeak) values are taken from the anesthesia device data,
2. BIS (from routine BIS monitoring)
3. Temperature (routinely from pharyngeal temperature probe),
4. Oxygen saturation (routinely from the patient monitor)
5. End-tidal CO₂,
6. inspiratory O₂ concentration,
7. Inspiratory CO2 concentration,
8. inspiratory and expiratory desflurane concentrations,
9. tidal volume,
10. MAC is routinely obtained from anesthesia device data.
11. Blood Gas Analysis (COHgb, Ph, PO2, PCO2, SaO2, HCO3, Base deficit, glucose, lactate)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* hearing problems;
* anxiety, depression, or other psychiatric conditions;
* patient's request to leave the study
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Betül Güven
assoc. prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Betül Güven Aytaç
Role: PRINCIPAL_INVESTIGATOR
Ankara City Hospital Bilkent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara City Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TABED1-24-72
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.